Another great #CNshowmethesign tweetorial by #HouseTaussig ‘s ⭐️ Maryam Barkhordarian 👏🏻👏🏻

Join #HouseTaussig tomorrow for another great #CardsJC discussing #ULTIMATEDAPT 🔥 Tomorrow, 5/9, 8:00 PM EST Hope to see you all there!!

Calling CardioNerds everywhere! ♥️🤓, the May CardioNerds Journal Club is starting in 30 minutes! Let's discuss the ULTIMATE-DAPT trial. Ticagrelor monotherapy vs DAPT from month 1 to 12 after PCI 💊 #CardsJC #Housetaussig

To get situated: check out this powerful 👊🏼visual abstract crafted by our one and only Ramy Doss Full article below: 📰 thelancet.com/journals/lance… #CardsJC

Join in, ask & answer Qs, learn from our amazing content experts 👇🏾and CardioNerds Faculty, FITs & Family ❤ #CardsJC Poonam Velagapudi Ajar Kochar Karol Watson Moussa Mansour Oluwaseyi Bolorunduro Ali Nsair, MD Rani Hasan Ty Gluckman Mukta Srivastava Melissa Tracy Eugene Yang Seyi Bolorunduro MD MPH

Do you think these outcomes would be reproducible with other, potentially less potent, antiplatelet agents such as Clopidogrel? 💊 #CardsJC

And just as a quick reminder! Here is a great infographic reviewing BARC score for bleeding 🩸 by Kate Alta 👩🏼‍🦰

With previous trials such as SMART-DATE & STOPDAPT-2 STEMI suggesting potential harm with shorter DAPT in STEMI, & with the current population consistent of only 30% STEMI, how do you feel about extrapolation of this data to your STEMI population? #CardsJC

TODAY!

🔥 infographic on #IVUS vs #OCT by the brilliant Adriana C. Mares 😍👏🏻 CardioNerds #HouseTaussig x.com/adrianacmares/…

Excited to launch a series of #Cardiology imaging infographics, starting with a classic: TAPSE! These are meant to be quick, bite-sized graphics discussing key points for #MedEd Grateful to all CardioNerds for support! If any comments, feel free to share below

🤍🤍🤍

Coming up soon! Join Ari Cedars from Johns Hopkins Medicine and the ACHA for this free webinar. Register and learn more here: hopkins.org/asdwebinar

31 around the sun & having fun 🎂🥳 No better way to end the day than with my girl Luna resting in her favorite spot!🦜🤍

⚠️High CVP is key to the development of FALD⚠️ Breaking it down: High CVP ➡️ increased hepatic afterload ➡️ hepatic congestion ➡️ fibrosis ➡️ cirrhosis (+/- portal hypertension)

Cardiology Fellowship applicants: Interested in clinical research AND sports cardiology? Apply to Emory's Clinical Investigator Track- I am looking for a NEW superb fellow to begin July 2025! American College of Cardiology Emory Department of Medicine Emory Department of Medicine Austin Rim

RUBOTO, another failed pulmonary vasodilator trial in #Fontan. Perhaps we need to do a better job of identifying those who benefit and those who dont? Likely heterogeneous treatment effect. Alexander (Sasha) Opotowsky Alexander Vd Bruaene Swati Garekar pubmed.ncbi.nlm.nih.gov/39216715/

#FALD remains a vexing condition. FONLIVER score (elastography + Plt ct) performs well but not that much better than VAST, and VAST has outcomes data (here severe fibrosis histology was outcome). I'm sure more data to come. Swati Garekar Alexander Vd Bruaene pubmed.ncbi.nlm.nih.gov/39260705/

Wow, such an important study! Exercise impact on liver in #Fontan. Upshot: exercise, even high intensity, appears safe! Only 10 patients but granularity of physiologic assessment impressive. DONT RESTRICT! Alexander Vd Bruaene Alexander (Sasha) Opotowsky Shelby Kutty, MD, PhD, MHCM pubmed.ncbi.nlm.nih.gov/37219588/